Related Experiment Video
Updated: Jun 16, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Cellular therapy for repair of cardiac damage after acute myocardial infarction
Matthew M Cook1, Katarina Kollar, Gary P Brooke
1Adult Stem Cell Laboratory, Mater Medical Research Institute, South Brisbane, QLD 4101, Australia.
Insights
Cellular therapy offers a promising new avenue for treating cardiovascular diseases, including acute myocardial infarction. This review explores exogenous adult cell candidates and their potential to repair heart damage and improve cardiac function.
Area of Science:
- Regenerative Medicine
- Cardiology
- Cellular Biology
Background:
- Cardiovascular diseases are the leading global cause of mortality.
- Current treatments for conditions like acute myocardial infarction alleviate symptoms but do not reverse underlying damage.
- A significant unmet medical need exists for therapies that can directly repair cardiac tissue.
Purpose of the Study:
- To review notable exogenous adult cell candidates for cardiovascular disease therapy.
- To explore the mechanisms by which these cells may improve cardiac function post-myocardial infarction.
- To inform future clinical trial planning for cardiac cellular myoplasty.
Main Methods:
- Literature review of existing research on cellular therapy for cardiovascular diseases.
- Assessment of various exogenous adult stem and progenitor cell populations.
- Analysis of proposed mechanisms of action for cardiac repair.
Main Results:
- Several exogenous adult cell populations show potential for cardiac repair.
- These cells may mediate functional improvements following acute myocardial infarction through various mechanisms.
- The review synthesizes current understanding of cell-based approaches.
Conclusions:
- Cellular therapy represents a promising frontier for treating cardiovascular diseases.
- Further research into specific cell types and their mechanisms is crucial.
- This work supports the development of clinical trials for cardiac cellular myoplasty.
Abstract:
Cardiovascular diseases, particularly acute myocardial infarction, are the leading causes of death worldwide. Important advances have been made in the secondary treatment for cardiovascular diseases such as heart transplantation and medical and surgical therapies. Although these therapies alleviate symptoms, and may even improve survival, none can reverse the disease process and directly repair the lasting damage. Thus, the cure of cardiovascular diseases remains a major unmet medical need. Recently, cellular therapy has been proposed as a candidate treatment for this. Many stem and progenitor cell populations have each been suggested as a potential basis for such therapy. This review assesses some of the more notable exogenous adult cell candidates and provides insights into the mechanisms by which they may mediate improvement in cardiac function following acute myocardial infarction. Research into the cellular therapy field is of great importance for the further planning of clinical trials for cardiac cellular myoplasty.
More Related Videos
09:11Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014
08:03Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
Published on: March 30, 2022
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Cellular Injury II: Classification
Myocarditis III: Medical Management
Myocarditis I: Introduction
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care